Childhood trauma, HPA axis activity and antidepressant response in patients with depression.

Childhood trauma Cortisol response Glucocorticoid resistance HPA axis hyperactivity Inflammation Major depressive disorders Treatment resistant depression

Journal

Brain, behavior, and immunity
ISSN: 1090-2139
Titre abrégé: Brain Behav Immun
Pays: Netherlands
ID NLM: 8800478

Informations de publication

Date de publication:
07 2020
Historique:
received: 02 07 2019
revised: 27 11 2019
accepted: 27 11 2019
pubmed: 4 12 2019
medline: 28 4 2021
entrez: 4 12 2019
Statut: ppublish

Résumé

Childhood trauma is among the most potent contributing risk factors for depression and is associated with poor treatment response. Hypothalamic-pituitary-adrenal (HPA) axis abnormalities have been linked to both childhood trauma and depression, but the underlying mechanisms are poorly understood. The present study aimed to investigate the link between childhood trauma, HPA axis activity and antidepressant response in patients with depression. As part of the Wellcome Trust NIMA consortium, 163 depressed patients and 55 healthy volunteers were included in this study. Adult patients meeting Structured Clinical Interview for Diagnostic and Statistical Manual Version-5 criteria for major depression were categorised into subgroups of treatment responder (n = 42), treatment non-responder (n = 80) and untreated depressed (n = 41) based on current depressive symptom severity measured by the 17-item Hamilton Rating Scale for Depression and exposure to antidepressant medications established by Antidepressant Treatment Response Questionnaire. Childhood Trauma Questionnaire was obtained. Baseline serum C-reactive protein was measured using turbidimetric detection. Salivary cortisol was analyzed at multiple time points during the day using the ELISA technique. Glucocorticoid resistance was defined as the coexistence of hypercortisolemia and inflammation. Our results show that treatment non-responder patients had higher exposure to childhood trauma than responders. No specific HPA axis abnormalities were found in treatment non-responder depressed patients. Untreated depressed showed increased diurnal cortisol levels compared with patients on antidepressant medication, and higher prevalence of glucocorticoid resistance than medicated patients and controls. The severity of childhood trauma was associated with increased diurnal cortisol levels only in individuals with glucocorticoid resistance. Therefore, our findings suggest that the severity of childhood trauma experience contributes to a lack of response to antidepressant treatment. The effects of childhood trauma on increased cortisol levels are specifically evident in patients with glucocorticoid resistance and suggest glucocorticoid resistance as a target for the development of personalized treatment for a subgroup of depressed patients with a history of childhood trauma rather than for all patients with resistance to antidepressant treatment.

Identifiants

pubmed: 31794798
pii: S0889-1591(19)30702-0
doi: 10.1016/j.bbi.2019.11.024
pmc: PMC7327513
pii:
doi:

Substances chimiques

Antidepressive Agents 0
Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

229-237

Subventions

Organisme : Wellcome Trust
ID : 104025/Z/14/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K022202/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/J002739/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_G0802534
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 110049/Z/15/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N029488/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G108/603
Pays : United Kingdom
Organisme : MRF
ID : MRF_MRF-160-0005-ELP-MONDE
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Naghmeh Nikkheslat (N)

Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, UK. Electronic address: naghmeh.nikkheslat@kcl.ac.uk.

Anna P McLaughlin (AP)

Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, UK.

Caitlin Hastings (C)

Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, UK.

Zuzanna Zajkowska (Z)

Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, UK.

Maria A Nettis (MA)

Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, UK.

Nicole Mariani (N)

Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, UK.

Daniela Enache (D)

Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, UK.

Giulia Lombardo (G)

Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, UK.

Linda Pointon (L)

Department of Psychiatry, Behavioural and Clinical Neurosciences Institute, University of Cambridge, UK.

Philip J Cowen (PJ)

University Department of Psychiatry, Warneford Hospital, Oxford, UK.

Jonathan Cavanagh (J)

Mental Health and Wellbeing, Sackler Institute, Neurology Block, Queen Elizabeth University Hospital, Glasgow, UK.

Neil A Harrison (NA)

Department of Neuroscience, Brighton & Sussex Medical School, University of Sussex, Brighton, UK.

Edward T Bullmore (ET)

Department of Psychiatry, Behavioural and Clinical Neurosciences Institute, University of Cambridge, UK; GlaxoSmithKline R&D, Stevenage UK, Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge UK.

Carmine M Pariante (CM)

Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, UK; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, UK.

Valeria Mondelli (V)

Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, UK; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH